Aims Chagas disease, caused by the protozoan Trypanosoma cruzi is endemic in Latin America, and may lead to a life-threatening inflammatory dilated, chronic Chagas cardiomyopathy (CCC). One third of T. cruzi-infected individuals progress to CCC while the others remain asymptomatic (ASY). A possible genetic component to disease progression was suggested by familial aggregation of cases and the association of markers of innate and adaptive immunity genes with CCC development. Since mutations in multiple sarcomeric genes, including alpha-cardiac actin (ACTC1) have been involved in hereditary dilated cardiomyopathy, we investigated the involvement of the ACTC1 gene in CCC pathogenesis. Methods and Results We conducted a proteomic and genetic study on a Brazilian study population. The genetic study was done on a main cohort including 118 seropositive asymptomatic subjects and 315 cases and the replication was done on 36 asymptomatic and 102 CCC cases. ACTC1 protein and mRNA levels were lower in myocardial tissue from patients with end-stage CCC than those found in hearts from organ donors. Genotyping a case-control cohort of CCC and ASY subjects for all informative single nucleotide polymorphism (SNP) in the ACTC1 gene identified rs640249 SNP, located at the 5’ region, as associated to CCC. Associations are borderline after correction for multiple testing. Correlation and haplotype analysis led to the identification of a susceptibility haplotype. Functional assays have shown that the rs640249A/C polymorphism affects the binding of transcriptional factors in the promoter regions of the ACTC1 gene. Confirmation of the detected association on a larger independent replication cohort will be useful. Conclusions Genetic variations at the ACTC1 gene may contribute to progression to chronic Chagas Cardiomyopathy among T. cruzi-infected patients, possibly by modulating transcription factor binding to ACTC1 promoter regions.
References
[1]
Salvatella R (2007) Andean subregional Chagas disease area and the Andean initiative of Chagas disease. Mem Inst Oswaldo Cruz 102 Suppl 1: 39-40. doi:10.1590/S0074-02762007005000105. PubMed: 17906804.
[2]
Kirchhoff LV, Weiss LM, Wittner M, Tanowitz HB (2004) Parasitic diseases of the heart. Front Biosci 9: 706-723. doi:10.2741/1255. PubMed: 14766402.
[3]
Schofield CJ, Jannin J, Salvatella R (2006) The future of Chagas disease control. Trends Parasitol 22: 583-588. doi:10.1016/j.pt.2006.09.011. PubMed: 17049308.
[4]
Dias E, Laranja FS, Miranda A, Nobrega G (1956) Chagas' disease; a clinical, epidemiologic, and pathologic study. Circulation 14: 1035-1060. doi:10.1161/01.CIR.14.6.1035. PubMed: 13383798.
[5]
Martin UO, Afchain D, de Marteleur A, Ledesma O, Capron A (1987) Circulating immune complexes in different developmental stages of Chagas' disease. Medicina (B Aires) 47: 159-162.
[6]
Coura JR (2007) Chagas disease: what is known and what is needed--a background article. Mem Inst Oswaldo Cruz 102 Suppl 1: 113-122. PubMed: 17992371.
[7]
Mady C, Cardoso RH, Barretto AC, da Luz PL, Bellotti G et al. (1994) Survival and predictors of survival in patients with congestive heart failure due to Chagas' cardiomyopathy. Circulation 90: 3098-3102. doi:10.1161/01.CIR.90.6.3098. PubMed: 7994859.
[8]
Bestetti RB, Muccillo G (1997) Clinical course of Chagas' heart disease: a comparison with dilated cardiomyopathy. Int J Cardiol 60: 187-193. doi:10.1016/S0167-5273(97)00083-1. PubMed: 9226290.
[9]
Pereira Barretto AC, Mady C, Arteaga-Fernandez E, Stolf N, Lopes EA et al. (1986) Right ventricular endomyocardial biopsy in chronic Chagas' disease. Am Heart J 111: 307-312. doi:10.1016/0002-8703(86)90144-4. PubMed: 3946173.
[10]
Higuchi ML, De Morais CF, Pereira Barreto AC, Lopes EA, Stolf N et al. (1987) The role of active myocarditis in the development of heart failure in chronic Chagas' disease: a study based on endomyocardial biopsies. Clin Cardiol 10: 665-670. doi:10.1002/clc.4960101113. PubMed: 3677499.
[11]
Ribeirao M, Pereira-Chioccola VL, Renia L, Fragata Filho Augusto A. , Schenkman S et al. (2000) Chagasic patients develop a type 1 immune response to Trypanosoma cruzi trans-sialidase. Parasite Immunol 22: 49-53. doi:10.1046/j.1365-3024.2000.00260.x. PubMed: 10607290. Available online at: doi:10.1046/j.1365-3024.2000.00260.x. Available online at: PubMed: 10607290.
[12]
Abel LC, Rizzo LV, Ianni B, Albuquerque F, Bacal F et al. (2001) Chronic Chagas' disease cardiomyopathy patients display an increased IFN-gamma response to Trypanosoma cruzi infection. J Autoimmun 17: 99-107. doi:10.1006/jaut.2001.0523. PubMed: 11488642.
[13]
Teixeira MM, Gazzinelli RT, Silva JS (2002) Chemokines, inflammation and Trypanosoma cruzi infection. Trends Parasitol 18: 262-265. doi:10.1016/S1471-4922(02)02283-3. PubMed: 12036740.
[14]
Ferreira RC, Ianni BM, Abel LC, Buck P, Mady C, et al. (2003) Increased plasma levels of tumor necrosis factor-alpha in asymptomatic/"indeterminate" and Chagas disease cardiomyopathy patients. Mem Inst Oswaldo Cruz 98: 407-11.
[15]
Talvani A, Rocha MO, Barcelos LS, Gomes YM, Ribeiro AL et al. (2004) Elevated concentrations of CCL2 and tumor necrosis factor-alpha in chagasic cardiomyopathy. Clin Infect Dis 38: 943-950. doi:10.1086/381892. PubMed: 15034825.
[16]
Nogueira LG, Santos RH, Ianni BM, Fiorelli AI, Mairena EC et al. (2012) Myocardial Chemokine Expression and Intensity of Myocarditis in Chagas Cardiomyopathy Are Controlled by Polymorphisms in CXCL9 and CXCL10. PLoS Negl Trop. Drosophila Inf Service 6: e1867.
[17]
Cunha-Neto E, Dzau VJ, Allen PD, Stamatiou D, Benvenutti L et al. (2005) Cardiac gene expression profiling provides evidence for cytokinopathy as a molecular mechanism in Chagas' disease cardiomyopathy. Am J Pathol 167: 305-313. doi:10.1016/S0002-9440(10)62976-8. PubMed: 16049318.
[18]
Riol-Blanco L, Sánchez-Sánchez N, Torres A, Tejedor A, Narumiya S et al. (2005) The chemokine receptor CCR7 activates in dendritic cells two signaling modules that independently regulate chemotaxis and migratory speed. J Immunol 174: 4070-4080. PubMed: 15778365.
[19]
Sakai N, Wada T, Yokoyama H, Lipp M, Ueha S et al. (2006) Secondary lymphoid tissue chemokine (SLC/CCL21)/CCR7 signaling regulates fibrocytes in renal fibrosis. Proc Natl Acad Sci U S A 103: 14098-14103. doi:10.1073/pnas.0511200103. PubMed: 16966615.
[20]
Reddy VS, Harskamp RE, van Ginkel MW, Calhoon J, Baisden CE et al. (2008) Interleukin-18 stimulates fibronectin expression in primary human cardiac fibroblasts via PI3K-Akt-dependent NF-kappaB activation. J Cell Physiol 215: 697-707. doi:10.1002/jcp.21348. PubMed: 18064631.
[21]
Kubota T, Bounoutas GS, Miyagishima M, Kadokami T, Sanders VJ et al. (2000) Soluble tumor necrosis factor receptor abrogates myocardial inflammation but not hypertrophy in cytokine-induced cardiomyopathy. Circulation 101: 2518-2525. doi:10.1161/01.CIR.101.21.2518. PubMed: 10831527.
[22]
Reifenberg K, Lehr HA, Torzewski M, Steige G, Wiese E et al. (2007) Interferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice. Am J Pathol 171: 463-472. doi:10.2353/ajpath.2007.060906. PubMed: 17556594.
[23]
Bilate AM, Salemi VM, Ramires FJ, de Brito T, Silva AM et al. (2003) The Syrian hamster as a model for the dilated cardiomyopathy of Chagas' disease: a quantitative echocardiographical and histopathological analysis. Microbes Infect 5: 1116-1124. doi:10.1016/j.micinf.2003.07.001. PubMed: 14554253.
[24]
Zicker F, Smith PG, Netto JC, Oliveira RM, Zicker EM (1990) Physical activity, opportunity for reinfection, and sibling history of heart disease as risk factors for Chagas' cardiopathy. Am J Trop Med Hyg 43: 498-505. PubMed: 2240374.
[25]
Ramasawmy R, Cunha-Neto E, Fae KC, Martello FG, Müller NG et al. (2006) The monocyte chemoattractant protein-1 gene polymorphism is associated with cardiomyopathy in human chagas disease. Clin Infect Dis 43: 305-311. doi:10.1086/505395. PubMed: 16804844.
[26]
Cunha-Neto E, Nogueira LG, Teixeira PC, Ramasawmy R, Drigo SA et al. (2009) Immunological and non-immunological effects of cytokines and chemokines in the pathogenesis of chronic Chagas disease cardiomyopathy. Mem Inst Oswaldo Cruz 104 Suppl 1: 252-258. doi:10.1590/S0074-02762009000900032. PubMed: 19753481.
[27]
Teixeira PC, Frade AF, Nogueira LG, Kalil J, Chevillard C et al. (2012) Pathogenesis of Chagas disease cardiomyopathy. World Journal-- Clinical Infectious Diseases 2: 39-53. doi:10.5495/wjcid.v2.i3.39.
[28]
Ahmad F, Seidman JG, Seidman CE (2005) The genetic basis for cardiac remodeling. Annu Rev Genomics Hum Genet 6: 185-216. doi:10.1146/annurev.genom.6.080604.162132. PubMed: 16124859.
[29]
Dellefave L, McNally EM (2010) The genetics of dilated cardiomyopathy. Curr Opin Cardiol 25: 198-204. doi:10.1097/HCO.0b013e328337ba52. PubMed: 20186049.
[30]
Lu MH, DiLullo C, Schultheiss T, Holtzer S, Murray JM et al. (1992) The vinculin/sarcomeric-alpha-actinin/alpha-？actinnexus in cultured cardiac myocytes. J Cell Biol 117: 1007-1022. doi:10.1083/jcb.117.5.1007. PubMed: 1577864.
[31]
Gregorio CC (1997) Models of thin filament assembly in cardiac and skeletal muscle. Cell Struct Funct 22: 191-195. doi:10.1247/csf.22.191. PubMed: 9113406.
[32]
Olson TM, Michels VV, Thibodeau SN, Tai YS, Keating MT (1998) Actin mutations in dilated cardiomyopathy, a heritable form of heart failure. Science 280: 750-752. doi:10.1126/science.280.5364.750. PubMed: 9563954.
[33]
Jiang HK, Qiu GR, Li-Ling J, Xin N, Sun KL (2010) Reduced ACTC1 expression might play a role in the onset of congenital heart disease by inducing cardiomyocyte apoptosis. Circ J 74: 2410-2418. doi:10.1253/circj.CJ-10-0234. PubMed: 20962418.
[34]
Tostes S Jr, Rocha-Rodrigues D, de Araujo Pereira G, Rodrigues V (2005) Myocardiocyte apoptosis in heart failure in chronic Chagas' disease. Int J Cardiol 99: 233-7.
[35]
Foo RS, Mani K, Kitsis RN (2005) Death begets failure in the heart. J Clin Invest 115: 565-571. doi:10.1172/JCI24569. PubMed: 15765138.
[36]
Bilate AM, Teixeira PC, Ribeiro SP, Brito Td, Silva AM et al. (2008) Distinct outcomes of Trypanosoma cruzi infection in hamsters are related to myocardial parasitism, cytokine/chemokine gene expression, and protein expression profile. J Infect Dis 198: 614-623. doi:10.1086/590347. PubMed: 18598198.
[37]
Jorge MT, Macedo TA, Janones RS, Carizzi DP, Heredia RA et al. (2003) Types of arrhythmia among cases of American trypanosomiasis, compared with those in other cardiology patients. Ann Trop Med Parasitol 97: 139-148. doi:10.1179/000349803235001561. PubMed: 12803869.
[38]
van Veldhuisen DJ, Linssen GC, Jaarsma T, van Gilst WH, Hoes AW et al. (2013) B-type natriuretic peptide and prognosis in heart failure patients with preserved and reduced ejection fraction. J Am Coll Cardiol 61: 1498-1506. doi:10.1016/j.jacc.2012.12.044. PubMed: 23500300.
[39]
Januzzi JL Jr (2013) Natriuretic peptides, ejection fraction, and prognosis: parsing the phenotypes of heart failure. J Am Coll Cardiol 61: 1507-1509. doi:10.1016/S0735-1097(13)61507-7. PubMed: 23500284.
[40]
Teixeira PC, Santos RH, Fiorelli AI, Bilate AM, Benvenuti LA et al. (2011) Selective decrease of components of the creatine kinase system and ATP synthase complex in chronic Chagas disease cardiomyopathy. PLoS Negl Trop. Drosophila Inf Service 5: e1205.
[41]
Schmittgen TD, Livak KJ (2008) Analyzing real-time PCR data by the comparative C(T). Methods - Nat Protoc 3: 1101-1108. doi:10.1038/nprot.2008.73.
[42]
Barretto AC, Arteaga E, Mady C, Ianni BM, Bellotti G et al. (1993) Male sex. Prognostic factor in Chagas' disease. Arq Bras Cardiol 60: 225-227. PubMed: 8311729.
[43]
Faé KC, Drigo SA, Cunha-Neto E, Ianni B, Mady C et al. (2000) HLA and beta-myosin heavy chain do not influence susceptibility to Chagas disease cardiomyopathy. Microbes Infect 2: 745-751. doi:10.1016/S1286-4579(00)00501-3. PubMed: 10955954.
[44]
Basquiera AL, Sembaj A, Aguerri AM, Omelianiuk M, Guzmán S et al. (2003) Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction. Heart 89: 1186-1190. doi:10.1136/heart.89.10.1186. PubMed: 12975414.
[45]
Nyholt DR (2004) A simple correction for multiple testing for single-nucleotide polymorphisms in linkage disequilibrium with each other. Am J Hum Genet 74: 765-769. doi:10.1086/383251. PubMed: 14997420.
[46]
Nyholt DR (2005) Evaluation of Nyholt's procedure for multiple testing correction - author's reply. Hum Hered 60: 61-62. doi:10.1159/000087919. PubMed: 16137994.
[47]
Isnard A, Kouriba B, Doumbo O, Chevillard C (2011) Association of rs7719175, located in the IL13 gene promoter, with Schistosoma haematobium infection levels and identification of a susceptibility haplotype. Genes Immun 12: 31-39. PubMed: 20861864.
[48]
Beall CJ, Sepanski MA, Fyrberg EA (1989) Genetic dissection of Drosophila myofibril formation: effects of actin and myosin heavy chain null alleles. Genes Dev 3: 131-140. doi:10.1101/gad.3.2.131. PubMed: 2714648.
[49]
Krüger M, Linke WA (2009) Titin-based mechanical signalling in normal and failing myocardium. J Mol Cell Cardiol 46: 490-498. doi:10.1016/j.yjmcc.2009.01.004. PubMed: 19639676.
[50]
Knoll R, Buyandelger B, Lab M (2011) The sarcomeric Z-disc and Z-discopathies. J Biomed Biotechnol 2011: 569628.
[51]
Pulkki KJ (1997) Cytokines and cardiomyocyte death. Ann Med 29: 339-343. doi:10.3109/07853899708999358. PubMed: 9375993.
[52]
Mocelin AO, Issa VS, Bacal F, Guimar？es GV, Cunha E et al. (2005) The influence of aetiology on inflammatory and neurohumoral activation in patients with severe heart failure: a prospective study comparing Chagas' heart disease and idiopathic dilated cardiomyopathy. Eur J Heart Fail 7: 869-873. doi:10.1016/j.ejheart.2004.10.014. PubMed: 16043406.
